Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample
- PMID: 23024435
- PMCID: PMC3443763
- DOI: 10.5665/sleep.2116
Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample
Abstract
Study objectives: To evaluate the prevalence of severe insomnia symptoms and the extent to which they are associated with daytime impairments in comorbid mood and anxiety disorders.
Design: Nationally representative cross-sectional survey.
Setting: National Comorbidity Survey-Replication (NCS-R).
Participants: There were 5,692 NCS-R respondents with no mood or anxiety disorder (n = 3,711), mood disorders only (n = 327), anxiety disorders only (n = 1,137), and coexisting mood and anxiety disorders (n = 517).
Interventions: N/A.
Measurements and results: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition disorders and severe insomnia symptoms in the past year were assessed using the World Health Organization (WHO) Composite International Diagnostic Interview. The World Health Organization Disability Assessment Schedule (WHO-DAS) indexed eight domains of daytime impairment in the past 30 days, which included self-care, mobility, cognition, social functioning, time out of role, and four components of productive role functioning. Respondents with comorbid mood and anxiety disorders had significantly higher rates of severe insomnia complaints (42.1-62.8%) relative to the three other groups. Severe insomnia complaints were also significantly more prevalent in individuals with mood (25.2-45.6%) or anxiety disorders only (24.9-45.5%) relative to those with no disorder (12.4-24.3%). Moreover, endorsing a severe insomnia complaint in the past year was associated with increased days of impairment across all past-month WHO-DAS domains for respondents with mood-anxiety comorbidity. For the remaining groups, severe insomnia complaints were related to increased days of impairment across all domains except self-care, and additionally mobility for the group with mood disorders only.
Conclusions: Comorbid mood and anxiety disorders are associated with high rates of severe insomnia complaints, which were independently associated with substantial functional impairment.
Keywords: Mood disorders; anxiety disorders; insomnia.
Similar articles
-
Insomnia among current and remitted common mental disorders and the association with role functioning: results from a general population study.Sleep Med. 2016 Sep;25:34-41. doi: 10.1016/j.sleep.2016.07.015. Epub 2016 Aug 26. Sleep Med. 2016. PMID: 27823713
-
Insomnia and role impairment in the community : results from the Nigerian survey of mental health and wellbeing.Soc Psychiatry Psychiatr Epidemiol. 2007 Jun;42(6):495-501. doi: 10.1007/s00127-007-0183-2. Epub 2007 Apr 21. Soc Psychiatry Psychiatr Epidemiol. 2007. PMID: 17450457
-
Health correlates of insomnia symptoms and comorbid mental disorders in a nationally representative sample of US adolescents.Sleep. 2015;38(2):197-204. doi: 10.5665/sleep.4396. Sleep. 2015. PMID: 25325502 Free PMC article.
-
Diagnosis, prevalence, pathways, consequences & treatment of insomnia.Indian J Med Res. 2010 Feb;131:321-32. Indian J Med Res. 2010. PMID: 20308757 Free PMC article. Review.
-
Sleep and Mood Disorders Among Youth.Child Adolesc Psychiatr Clin N Am. 2021 Jan;30(1):251-268. doi: 10.1016/j.chc.2020.09.003. Epub 2020 Oct 27. Child Adolesc Psychiatr Clin N Am. 2021. PMID: 33223065 Free PMC article. Review.
Cited by
-
Chronic insomnia, high trait anxiety and their comorbidity as risk factors for incident type 2 diabetes mellitus.Sci Rep. 2024 May 24;14(1):11927. doi: 10.1038/s41598-024-62675-y. Sci Rep. 2024. PMID: 38789594 Free PMC article.
-
Relationship between insomnia and pain in patients with chronic orofacial pain.Pain Med. 2024 May 2;25(5):319-326. doi: 10.1093/pm/pnae003. Pain Med. 2024. PMID: 38258535
-
Investigating the Role of BDNF in Insomnia: Current Insights.Nat Sci Sleep. 2023 Dec 7;15:1045-1060. doi: 10.2147/NSS.S401271. eCollection 2023. Nat Sci Sleep. 2023. PMID: 38090631 Free PMC article. Review.
-
Daily diary study of associations between alcohol, cannabis, co-use and sleep quality in individuals with intentions to use cannabis to cope with anxiety.Drug Alcohol Rev. 2024 Feb;43(2):501-511. doi: 10.1111/dar.13778. Epub 2023 Nov 20. Drug Alcohol Rev. 2024. PMID: 37985016
-
The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic Depression.J Clin Psychopharmacol. 2023 Nov-Dec 01;43(6):486-492. doi: 10.1097/JCP.0000000000001756. Epub 2023 Aug 31. J Clin Psychopharmacol. 2023. PMID: 37930199 Free PMC article. Clinical Trial.
References
-
- Robins LN, Locke BZ, Regier DA. An overview of psychiatric disorders in America. In: Robins LN, Regier DA, editors. Psychiatric disorders in America: the epidemiologic catchment area study. New York, NY: Free Press; 1991. pp. 328–66.
-
- Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19. - PubMed
-
- Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry Suppl. 1998;34:24–8. - PubMed
-
- Zimmerman M, Chelminski I, McDermut W. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry. 2002;63:187–93. - PubMed
-
- Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289:3095–105. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous